Page 21 - MemoriaCIBER-2018ENG

Transfer
One of the CIBER’S main aims is the translation of the knowledge generated by its researchers, in such a way that the results of research are implemented in protocols, services and products for the improvement of clinical practice and
the population’s quality of life. To materialise this the Technology Transfer area of the CIBER works as a liaison between our researchers
and companies, private organisations, public research centres and other innovation agents to put cooperation between them into practice and
21
THEMATIC AREA
CIBERDEM
CIBERER
CIBERESP
CIBERSAM
CIBERONC
Priority patent applications
Other IPRs and software
Licences and licence options
make sure that the results of research can finally be applied.
In 2018 23 new applications for patents were submitted at the CIBER, with 1 intellectual property registration (CIBERSAM), 1 trademark (CIBERDEM) and 2 software (CIBERCV and CIBERBBN). 4 licence contracts and 1 licence option contract (CIBERES) were also signed.
CIBER-BBN
CIBEREHD
8
1
-
3
2
1
-
1
-
6
-
1
CIBERES
3
-
1*
CIBEROBN
-
-
-
-
2
-
1
1
-
CIBERCV
-
1
-
-
-
-
CIBERFES
-
-
-
Two new orphan designations were also obtained for Fanconi anaemia, which means 8 orphan drugs sponsored by the CIBER until now (CIBERER area).
As an example of this, other measures concerning knowledge transfer and public- private cooperation that have been performed are:
• Dozens of CDAs and MTAs negotiated and signed.
• Assistance and participation in a large number of partnering and discussion forums, including: Biospain, BioEquity Europe, BioEurope, Workshop Kaertor, Transfiere Forum, as well as at other international, national and regional fairs and forums.
*Licence option
CIBER | ANNUAL REPORT 2018